Titawattanakul Y, Kulvichit K, Varadisai A, et al. - Researchers conducted the study for analyzing the unfavorable outcomes and regression after pre-early treatment for retinopathy of prematurity (ROP). From January 2009 to January 2014, the data were retrieved retrospectively from the medical records of all infants who were screened and treated for ROP at a tertiary care facility. Findings revealed that there were 91 eyes with stage 3 ROP. There were 63 eyes in the pre-ETROP group and 28 in the ETROP group, out of a total of 91 eyes. For reducing unfavorable outcomes and increasing the regression of ROP, the pre-ETROP treatment is useful. In addition, the treatment can reduce the recurrence of neovascularization and post-treatment progression.